Susquehanna International Group
PHAT icon

Susquehanna International Group’s Phathom Pharmaceuticals PHAT Stock Holding History

Susquehanna International Group’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.03M Sell
92,979
-456,192
-83% -$5.76M ﹤0.01% 7809
2025
Q4 		$9.11M Buy
549,171
+394,894
+256% +$5.64M ﹤0.01% 3173
2025
Q3 		$1.82M Buy
154,277
+20,069
+15% +$207K ﹤0.01% 5995
2025
Q2 		$1.29M Sell
134,208
-26,930
-17% -$149K ﹤0.01% 6799
2025
Q1 		$1.01M Sell
161,138
-74,266
-32% -$451K ﹤0.01% 7238
2024
Q4 		$1.91M Buy
235,404
+56,734
+32% +$703K ﹤0.01% 5416
2024
Q3 		$3.23M Buy
+178,670
New +$2.5M ﹤0.01% 4406
2024
Q2 		– Sell
-59,437
Closed -$612K – 12947
2024
Q1 		$631K Buy
59,437
+7,124
+14% +$60.5K ﹤0.01% 7951
2023
Q4 		$478K Buy
+52,313
New +$451K ﹤0.01% 8782
2023
Q3 		– Sell
-63,408
Closed -$870K – 12730
2023
Q2 		$908K Sell
63,408
-83,008
-57% -$957K ﹤0.01% 6907
2023
Q1 		$1.05M Buy
146,416
+119,849
+451% +$1.05M ﹤0.01% 6701
2022
Q4 		$298K Buy
26,567
+2,668
+11% +$27.5K ﹤0.01% 9116
2022
Q3 		$265K Buy
+23,899
New +$228K ﹤0.01% 10116
2021
Q2 		– Sell
-26,505
Closed -$949K – 13082
2021
Q1 		$996K Buy
26,505
+2,246
+9% +$94K ﹤0.01% 7751
2020
Q4 		$806K Buy
+24,259
New +$983K ﹤0.01% 7206

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Susquehanna International Group's PHAT Position: Q1 2026 in Review

Susquehanna International Group reduced its Phathom Pharmaceuticals (PHAT) stake by 83% in Q1 2026, selling an estimated $5.76M and leaving 92,979 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #7809.

Susquehanna International Group first reported a position in PHAT in Q4 2020 and has held it in 15 quarters since. The position peaked at $9.11M in Q4 2025. 174 funds tracked by Wall St. Rank hold PHAT as of Q1 2026.

  • Susquehanna International Group held 92,979 shares of Phathom Pharmaceuticals worth $1.03M as of Q1 2026.
  • Susquehanna International Group sold 456,192 Phathom Pharmaceuticals shares in Q1 2026, an estimated $5.76M.
  • Phathom Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7809 holding.
  • Susquehanna International Group first reported a position in Phathom Pharmaceuticals in Q4 2020 and has held it in 15 quarters since.
  • Susquehanna International Group's Phathom Pharmaceuticals position peaked at $9.11M in Q4 2025.
  • 174 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.